Warnyta Minnaard

Warnyta Minnaard

If the practitioner doesn’t know where the primary tumor is located, they cannot offer a targeted treatment plan, and nor can they give the patient an estimate of their life expectancy.

Back to news

More news

Oncoanalyser 3.0 for cancer genomics is out, now supporting Illumina, Ultima Genomics & Roche platforms

Oncoanalyser 3.0 for cancer genomics is out, now supporting Illumina, Ultima Genomics & Roche platforms

04-09-2026

Extensive work on the underlying WiGiTS tools now enable users to analyze sequencing data from three sequencing platforms (Illumina, Ultima …

The starting point – always the patient

The starting point – always the patient

04-10-2024

Frank van Wijck, science journalist  Ele Visser is handing over his position as chairman of Hartwig Medical Foundation’s Data Access Board …

Collaboration for future-proof diagnostics and to accelerate research  

Collaboration for future-proof diagnostics and to accelerate research  

02-05-2023

Complete analysis of the DNA of children with cancer offers many possibilities. It maps out all possible targeted treatment options …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl